Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer
文献类型:期刊论文
作者 | Bu Xianmin; Zhao Chenghai; Dai Xianwei |
刊名 | CHINESE MEDICAL JOURNAL
![]() |
出版日期 | 2008 |
卷号 | 121期号:10页码:952-955 |
关键词 | PROSTATE-CANCER GENE METHYLATION HYPERMETHYLATION TUMORIGENESIS CARCINOMA SFRP1 Wnt hypermethylation pancreatic cancer |
ISSN号 | 0366-6999 |
其他题名 | Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer |
英文摘要 | Pancreatic cancer is one of the malignant tumor with a very poor prognosis. Both genetic and epigenetic alterations are involved in the pathogenetic mechanisms of pancreatic cancer. Hypermethylation and subsequent loss of expression of some tumor suppressor genes and tumor-related genes occur frequently in pancreatic cancer, such as loss of expression of pl6,1 RASSF1A,2 SOCS-1,3 and hMLH14 genes were repoted. |
语种 | 英语 |
CSCD记录号 | CSCD:3383548 |
源URL | [http://ir.imr.ac.cn/handle/321006/157558] ![]() |
专题 | 金属研究所_中国科学院金属研究所 |
作者单位 | 中国科学院金属研究所 |
推荐引用方式 GB/T 7714 | Bu Xianmin,Zhao Chenghai,Dai Xianwei. Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer[J]. CHINESE MEDICAL JOURNAL,2008,121(10):952-955. |
APA | Bu Xianmin,Zhao Chenghai,&Dai Xianwei.(2008).Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer.CHINESE MEDICAL JOURNAL,121(10),952-955. |
MLA | Bu Xianmin,et al."Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer".CHINESE MEDICAL JOURNAL 121.10(2008):952-955. |
入库方式: OAI收割
来源:金属研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。